Pregled bibliografske jedinice broj: 1192661
Outcome in elderly patients with ANCA – associated glomerulonephritis managed with immunosuppressive treatment
Outcome in elderly patients with ANCA – associated glomerulonephritis managed with immunosuppressive treatment // Acta clinica Croatica. Supplement, 60 (2021), 1; 148-154 doi:10.20471/acc.2021.60.s1.22 (domaća recenzija, članak, znanstveni)
CROSBI ID: 1192661 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Outcome in elderly patients with ANCA
– associated glomerulonephritis managed
with immunosuppressive treatment
Autori
Kurtov, Karlo ; Laganović, Mario ; Karanović, Sandra ; Dika, Živka ; Ivandić, Ema ; Živko, Marijana ; Kos, Jelena ; Fištrek, Margareta ; Jelaković, Bojan ; Vuković Brinar, Ivana
Izvornik
Acta clinica Croatica. Supplement (0353-9474) 60
(2021), 1;
148-154
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
antineutrophil cytoplasmic antibodies ; glomerulonephritis ; elderly ; immunosuppression ; mortality ; kidney failure
Sažetak
The most common cause of rapidly progressive glomerulonephritis in elderly, anti- neutrophil cytoplasmic antibody-associated glomerulonephritis (AnCA-gn), demands immunosuppressive therapy (iS) regimen in a multi-morbid disease burdened population. Our aim was to assess outcome differences in two age groups. The study included a total of 38 AnCA-gn renal limited patients (18 men) treated from 1990 to 2018, of which 11 were 65 years of age and older (median 70, min. - max. 66 - 79 years), and 27 younger than 65 (median 55, min. - max. 23 - 64 years). All patients were treated with mono/combination of iS. Most commonly applied iS in elderly was combination of iv cyclophosphamide and corticosteroids (CS) (in 9 [81.8%]), while in younger it was a combination of CS and cyclophosphamide or rituximab (59.2%). Older patients had comparable mortality (3, [14.8%] vs. 4, [27.3%] ; P = 0.369), malignancies (1, [3.7%] vs. 1, [9.1%] ; P = 0.5) and infectious complications (10, [46.7%] vs. 7, [63.6%] ; P = 0.388). ten patients at the end of the follow up were at renal replacement therapy (rrt), with no difference between age groups (6, [22.2%] vs. 4, [36.4%] ; P = 0.369). interestingly, from initial need for rrt, half of the younger and older patients recovered with iS. Our findings give more credit to the current paradigm to treat elderly AnCA-gn patients with iS therapy due to the similar outcome of elderly as younger ones.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Marijana Živko
(autor)
Sandra Karanović
(autor)
Bojan Jelaković
(autor)
Mario Laganović
(autor)
Ivana Vuković Brinar
(autor)
Živka Dika
(autor)